Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06072443 · ClinicalTrials.gov registry record
AURORA Study-A Transformative Approach to Support PrEP Medication Persistence
A clinical trial of HIV Infections, sponsored by WV Health Right.
- Recruiting
- Registry status
- 105
- Enrollment target
- 1
- Study location
NCT06072443: Recruiting study of HIV Infections, sponsored by WV Health Right.
NCT06072443 is a study of HIV Infections that is actively recruiting participants, run by WV Health Right. The registered enrollment target is 105 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06072443, a study of HIV Infections, is actively recruiting participants, sponsored by WV Health Right.
- RECRUITING
- Registry status
- 105 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed to test the hypothesis that, compared to oral PrEP, use of CAB-LA in underserved populations in a real-world setting supported by a digital health companion program will be associated with greater medication adherence, persistence, retention-in-care, and improved PROs. Patients in the study will receive current standard care for HIV prevention and be offered enrollment in the digital health companion program. Goal of the study is to evaluate medication adherence and persistence in patients receiving CAB-LA vs oral PrEP and who engage with a digital health companion program.
Conditions Studied
Interventions
- BEHAVIORAL Digital Health Companion (mobile App)
Study Locations (1)
West Virginia
- West Virginia Health Right - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2023-11-30 |
| Est. Completion | 2025-06-30 |
What NCT06072443 shows while recruiting
NCT06072443 is an observational study that tracks outcomes without assigning an intervention. The registered 105 participants enrollment target is mid-sized for trials with a published cap, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (76% lower).
The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Digital Health Companion (mobile App) is the first listed.
NCT06072443 reports a single indexed study location in West Virginia.
Frequently Asked Questions
What is clinical trial NCT06072443 about?
NCT06072443 is a clinical study titled "AURORA Study-A Transformative Approach to Support PrEP Medication Persistence". This study is designed to test the hypothesis that, compared to oral PrEP, use of CAB-LA in underserved populations in a real-world setting supported by a digital health companion program will be associated with greater medication adherence, persistence, retention-in-care, and improved PROs. Patient...
What is the current status of trial NCT06072443?
This trial is currently recruiting. The enrollment target is 105 participants. The study started on 2023-11-30. Estimated completion is 2025-06-30.
What conditions does trial NCT06072443 study?
This clinical trial studies the following conditions: HIV Infections.
What interventions are being tested in trial NCT06072443?
The interventions under investigation include: Digital Health Companion (mobile App) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06072443?
This trial is sponsored by WV Health Right, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06072443 being conducted?
This trial has 1 study location across West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06072443's enrollment target sits among peer trials
105 259th of 542 higher than 283 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
CAR-T Cells for HIV Infection
RECRUITING · Phase 1
-
A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV
RECRUITING · Phase 1
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03372317 · 105 participants
Tau PET in Imaging and Cognition: Healthy Adults From 55-90
- NCT04253964 · 105 participants · Phase 2
Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy
- NCT04742452 · 105 participants · NA
Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears
- NCT04875429 · 105 participants · NA
Zenith® Fenestrated+ Clinical Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI